Nobivac Tricat Trio, Lyophilisate and Solvent for Suspension for Injection for Cats

Cats:
Very common
(> 1 animal / 10 animals treated):
Injection site swelling.
Sneezing, cough, nasal discharge, dullness,
decreased appetite.
Common
(1 to 10 animals / 100 animals
treated):
Elevated temperature.
Very rare
(< 1 animal / 10,000 animals
treated, including isolated
reports):
Injection site pain, injection site hair loss,
injection site pruritus.
Hypersensitivity reactions (e.g. pruritus,
dyspnoea, vomiting, diarrhoea and collapse
including anaphylaxis).
Febrile limping syndrome reactions in kittens.
1
Local swelling 5 mm), sometimes painful, may occur at the injection site 1 – 2 days
post-vaccination.
May be observed for up to 2 days post-vaccination.
Elevated body temperature (up to 40 °C) may occur for 1 – 2 days post-vaccination.
Sometimes fatal. If such a reaction occurs, appropriate treatment should be
administered without delay.
As reported in the literature, febrile limping syndrome reactions in kittens may occur
after the use of any vaccine containing a feline calicivirus component.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See section “Contact details” of
the package leaflet.